Lv1
80 积分 2025-09-18 加入
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
12天前
已完结
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
12天前
已完结
A Comparison of Coagulation Function in Patients Receiving Aspirin and Cefoperazone-Sulbactam With and Without Vitamin K1: A Retrospective, Observational Study
1个月前
已完结
Severe coagulation dysfunction and active bleeding induced by cefoperazone/sulbactam in a patient with severe renal insufficiency: a case report
1个月前
已关闭
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update
8个月前
已完结
Real-world safety of carboplatin in non-small cell lung cancer: a retrospective signal detection and subgroup analysis based on the FAERS database
10个月前
已完结
Tyrosine kinase inhibitors-associated interstitial lung disease used in non-small cell lung cancer: a pharmacovigilance analysis based on the FDA adverse event reporting system database
10个月前
已完结
皖公网安备34019202002308
